Uptick Newswire Hosts Applied Biosciences Corp. on The Stock Day Podcast to Discuss The Expansion of Their CBD Product Lines

PHOENIX, AZ / ACCESSWIRE / April 18, 2019 / Uptick Newswire Stock Day Podcast welcomed Applied Biosciences Corp. (APPB) (''the Company''), a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. Treasurer and Secretary, JJ Southard, joined Stock Day host Everett Jolly.

Jolly began the interview by asking Southard to give listeners an update on the Company's current projects. Southard explained that throughout 2018 the Company focused on the development of their CBD line, Remedi, which has an extensive collection of products including CBD infused creams, drops, gummies, and even newly released Nano CBD Shots.

The Company has also launched their Herbal Pet line, which features CBD infused treats and tinctures for dogs, cats, and horses. Southard shared that the quality of the products within their Remedi and Herbal Pet line are of the highest quality available on the market, which is proven by the Company's increasing traffic and distribution.

Jolly then asked Southard how the Company has achieved its impressive growth over the past year. Southard explained that growth is a reflection of the success of their retail product line sales. Southard also shared that for 2019 the Company plans to expand on their existing product line, as well as create a new product line focused towards the specialized needs of athletes. ''We're close to launching our Champ Organics line which will expand our addressable market'', Southard stated

Southard also shared that the Company's partnership with Trace Analytics will also be reflecting revenues for the first quarter of 2019. This partnership represents the Testing & Analytics division of the Company, which they are looking to develop further.

To close the interview, Southard shared his excitement for the Company's therapeutic, wellness and spa lines and future product expansion and encouraged listeners to check out their exciting additions to the CBD retail market over the coming months.

To hear JJ Southard's entire interview, follow the link to the podcast here: https://upticknewswire.com/featured-interview-secretary-j-j-southard-of-applied-biosciences-corp-otcqb-appb/

Investors Hangout is a proud sponsor of ''Stock Day'', and Uptick Newswire encourages listeners to visit the company's message board at https://investorshangout.com/

About Applied BioSciences Corp.:

Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries. The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

The company has several strategic partnerships and investments currently in place and is actively pursuing additional partnerships and strategic growth opportunities.

Contact:

Email: [email protected] or [email protected]

To be added to the Applied BioSciences email distribution list, please email [email protected] with APPB in the subject line.

Official Website: www.appliedbiocorp.com

Safe Harbor Statement:

Except for historical information contained herein, statements in this release may be forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as ''anticipate'', ''believe'', ''estimate'', ''expect'', ''intend'' and similar expressions, as they relate to Applied Biosciences Corp. (the ''Company'') or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in the Company's filings with the Securities and Exchange Commission. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as (i) the development and protection of our brands and other intellectual property, (ii) the need to raise capital to meet business requirements, (iii) significant fluctuations in marketing expenses, (iv) the ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of our products and services, (v) the Company's ability to conduct the business if there are changes in laws, regulations, or government policies related to cannabis, (vi) management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and (vii) other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.